RTOG 0924: Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

CTO - 7025
Cancer Genitourinary/ Prostate
  • Males at least 18 years of age
  • Pathologically proven diagnosis of prostatic adenocarcinoma within 180 days of registration at a moderate to high risk for recurrence as determined by Gleason scores
Tiffany Pearce